Compare Bristol-Myers Squibb Co (BMY) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Rush Street Interactive Inc — how do they compare? Bristol-Myers Squibb Co trades at $58.7 (market cap $116.30B), while Rush Street Interactive Inc trades at $34.26 (market cap $3.45B). The key difference: Bristol-Myers Squibb Co is far larger — about 33.7× Rush Street Interactive Inc's market cap, and Bristol-Myers Squibb Co pays a 4.42% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| BMY | RSI | |
|---|---|---|
Market Cap | $116.30B | $3.45B |
Sector | Health | Technology |
52-Week High | $62.37 | $34.18 |
52-Week Low | $42.60 | $14.51 |
Enterprise Value | $152.24B | $3.12B |
Dividend Yield | 4.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
RSI stock trades at $34.18, up 2.34% today, with a bullish technical signal from moving averages and strong institutional support. Recent Q1 2026 earnings beat expectations with EPS of $0.14 versus $0.12 expected, while revenue grew to $1.13B in 2025. The company expanded into Alberta with BetRivers launch, enhancing its online gaming footprint.
Outlook remains positive with 76.9% analyst buy ratings and a consensus price target of $29.44, though high valuation multiples (P/E 98.56) and overbought RSI levels near 77.56 pose near-term risks. Key catalysts include Q2 2026 earnings on July 29, 2026, and execution of the $100M share repurchase program.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
